# Alembic Pharmaceuticals (NSE: APLLTD) — share price, financials and shareholding

Source: https://companystockprice.com/stocks/alembic-pharmaceuticals

## Key facts
- Company: Alembic Pharmaceuticals Limited
- NSE symbol: APLLTD (BSE code 533573)
- ISIN: INE901L01018
- Last close: ₹819.00 (-0.78%)

## About
Alembic Pharmaceuticals Limited, an integrated pharmaceutical company, develops, manufactures, markets, and sells pharmaceutical products in India and internationally. The company provides products in various therapeutic areas, such as cardiology, orthopaedics, anti-diabetic, ophthalmology, gynaecology, nephrology, gastrology, urology, dermatology, anti-infective, cold and cough, and animal health; generics formulations in oral solids, oncology oral solids and injectables, general injectables and ophthalmic products, dermatology, and oral suspension; and active pharmaceutical ingredients. It also exports its products. Alembic Pharmaceuticals Limited was founded in 1907 and is headquartered in Vadodara, India.

## FAQ
**What is the Alembic Pharmaceuticals company stock price today?**
Alembic Pharmaceuticals (APLLTD) last traded at ₹819.00 on the NSE, down 0.78% from the previous close.

**What is the market cap of Alembic Pharmaceuticals?**
Alembic Pharmaceuticals has a market capitalisation of about ₹16,099 crore.

**What is the P/E ratio of Alembic Pharmaceuticals?**
Alembic Pharmaceuticals trades at a price-to-earnings ratio of 23.2 based on trailing twelve-month earnings.

**What is the 52-week high and low of Alembic Pharmaceuticals?**
The 52-week high of Alembic Pharmaceuticals shares is ₹998.00 and the 52-week low is ₹635.80.

**What is the NSE symbol of Alembic Pharmaceuticals?**
Alembic Pharmaceuticals trades on the National Stock Exchange of India under the symbol APLLTD, and on the BSE under scrip code 533573. Its ISIN is INE901L01018.

**When was Alembic Pharmaceuticals listed on the NSE?**
Alembic Pharmaceuticals was listed on the NSE on 20 September 2011.

---
Prices may be delayed. Informational only, not investment advice. Methodology: https://companystockprice.com/methodology